1,1'-Carbonyldiimidazole → (S)-N-[5-(4-Methylpiperazin-1-yl)-3,4 dihydro-2H-1-benzopyran-3-yl)-4-(morpholinocarbonyl)benzamide

HRID 1017615Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1017615
[O:1]1[CH2:6][CH2:5][N:4]([C:7]([C:9]2[CH:17]=[CH:16][C:12]([C:13]([OH:15])=O)=[CH:11][CH:10]=2)=[O:8])[CH2:3][CH2:2]1.C(N1C=CN=C1)([N:20]1C=CN=C1)=O.N[C@H]1C[C:35]([N:37]2[CH2:42][CH2:41][N:40](C)[CH2:39][CH2:38]2)=COC1.[O:44]1[C:49]2[CH:50]=[CH:51][CH:52]=[CH:53][C:48]=2[CH:47]=[CH:46][CH2:45]1>CN(C)C=O>[CH3:35][N:37]1[CH2:42][CH2:41][N:40]([C:53]2[C:48]3[CH2:47][C@H:46]([NH:20][C:13](=[O:15])[C:12]4[CH:11]=[CH:10][C:9]([C:7]([N:4]5[CH2:3][CH2:2][O:1][CH2:6][CH2:5]5)=[O:8])=[CH:17][CH:16]=4)[CH2:45][O:44][C:49]=3[CH:50]=[CH:51][CH:52]=2)[CH2:39][CH2:38]1

Komponenten

5

Edukt 3

HCID 682631,1'-Carbonyldiimidazole2×HCID 47142364-(Morpholine-4-carbonyl)benzoic acidHCID 69212987(S)-3-Amino-5-(4-methylpiperazin-1-yl)-3,4 dihydropyran 2H-1-benzopyran

Produkt 1

HCID 69211129(S)-N-[5-(4-Methylpiperazin-1-yl)-3,4 dihydro-2H-1-benzopyran-3-yl)-4-(morpholinocarbonyl)benzamideAusbeute 53 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228DimethylformamideLösungsmittel2×

Reaktionsbedingungen

Temperatur
75 °C

Versuchsvorschrift

4-(Morpholinocarbonyl)benzoic acid (100 mg, 0.43 mmol; described in: J. Med. Chem. 1994, 37(26), 4538-4554) and 1,1′-carbonyldiimidazole (76 mg, 0.47 mmol) were dissolved in N,N-dimethylformamide (3 mL) and heated to 75° C. for 3.5 h. Additional 1,1′-carbonyldiimidazole (36 mg, 0.22 mol) was added and the solution was stirred for 30 min. (S)-3-Amino-5-(4-methylpiperazin-1-yl)-3,4 dihydropyran-2H-1-benzopyran (100 mg, 0.40 mmol), dissolved in N,N-dimethylformamide (2 mL), was added and the reaction mixture was stirred for 18 h at 50° C. The solvent was evaporated and the residue was partitioned between ethyl acetate (30 mL) and water (5 mL). The organic layer was washed with water (5 mL) and brine (5 mL) and dried (MgSO4). The solvent was evaporated in vacuo giving 180 mg of a crude product. Purification by preparative TLC twice using chloroform/methanol/concentrated ammonia 95:5:0.5 and chloroform/ethanol (saturated with NH3) 12:1 as the eluents afforded 98 mg (53% yield) of the title compound as a white solid: mp 222° C. (decomposes); EIMS(70 eV) m/z (relative intensity) 464 (68, M30 ); [α]22D−12° (c 0.44, chloroform).

Aufarbeitung

  1. additionwas added
  2. customThe solvent was evaporated
  3. customthe residue was partitioned between ethyl acetate (30 mL) and water (5 mL)
  4. washThe organic layer was washed with water (5 mL) and brine (5 mL)
  5. dry with materialdried (MgSO4)
  6. customThe solvent was evaporated in vacuo
  7. customgiving 180 mg of a crude product
  8. customPurification by preparative TLC twice using chloroform/methanol/concentrated ammonia 95:5:0.5 and chloroform/ethanol (saturated with NH3) 12:1 as the eluents

Quellen und Nachweise

ORD-Eintrag
ord-58eb493013774fdfbf214494076492ac
Quelldatensatz
uspto-grants-2002_11
Patentnummer
US06479497B1

Notizen zur Reaktion

Wird geladen…